Starlit Pharma Ceuticals Pvt Ltd
About Starlit Pharma Ceuticals Pvt Ltd
Data last updated:
Starlit Pharma Ceuticals Pvt Ltd is a private limited company based in Kolkata, West Bengal, India. It operates in the investment and credit NBFC segment of the financial services sector. It was incorporated on 21 January 1992 and has been in existence for over 34 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24234WB1992PTC054185.
The company has an authorised share capital of ₹3.5 Cr and a paid-up capital of ₹3.41 Cr. It is led by directors Manoj Jain and Rajesh Kumar Jain.
Its last annual general meeting (AGM) was held on 06 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 6B Bentinck Street1St Floor Aloka House, Kolkata, West Bengal, India – 700001.
As per the financials filed for FY 2025, the company reported a revenue of ₹43.76 Lakh, a growth of 28% compared to the previous year. For the same year it recorded a net loss of ₹2.55 Lakh (net margin -5.8%) and EBITDA of -₹2.51 Lakh (EBITDA margin -5.7%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 5% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Starlit Pharma Ceuticals Pvt Ltd's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address6B Bentinck Street1St Floor Aloka House, Kolkata, West Bengal, India – 700001
- IndustryFinancial Services, Investment & Credit NBFC, NBFC
To see the full contact details of Starlit Pharma Ceuticals Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Starlit Pharma Ceuticals is financial and insurance service. In detail, this covers other financial activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| K | Financial and insurance Service | K8 | Other financial activities |
To see the full business activity and turnover split of Starlit Pharma Ceuticals Pvt Ltd, buy the company report.
Financials of Starlit Pharma Ceuticals Pvt Ltd
FY 2025 filings availableStarlit Pharma Ceuticals Pvt Ltd reported revenue of ₹43.76 Lakh (up 28% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 28% growth in the latest year. EBITDA fell 283% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.51 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.55 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -5.7% | ||||
| Net Profit Margin | -5.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Starlit Pharma Ceuticals Pvt Ltd, buy the company report.
Board of directors of Starlit Pharma Ceuticals Pvt Ltd
Starlit Pharma Ceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manoj Jain Also directs: Raipur Oil Products Pvt Ltd, Megapix Enterprises Private Limited, Meghna Saree Emporium Pvt Ltd and 1 more | Director | 06 Aug 1994 | 32 Years 2 Months | Current |
| Rajesh Kumar Jain | Director | 29 May 2006 | 20 Years 4 Months | Current |
Peer comparison
Starlit Pharma Ceuticals Pvt Ltd is compared with the 5 companies closest to it by revenue in the BFSI industry (NBFC Investment and Credit Companies, Small Non Deposit NBFC), with the same principal business activity (other financial activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Amrit Financial Services Pvt Ltd, | ₹43.92 Lakh (FY 2025) | -42.0% | Hyderabad, Telangana, India | |||
| Starlit Pharma Ceuticals Pvt Ltdthis company | ₹43.76 Lakh (FY 2025) | -₹2.55 Lakh | -5.8% | 28.0% | Kolkata, West Bengal, India | |
| Menchu's Finance Private Limited | ₹43.74 Lakh (FY 2025) | 88.0% | Chennai, Tamil Nadu, India | |||
| Eros Merchants Pvt Ltd | ₹43.71 Lakh (FY 2022) | 10.0% | Kolkata, West Bengal, India | |||
| Bhanumati Distributors Pvt.Ltd. | ₹43.71 Lakh (FY 2024) | -54.0% | Varanasi, Uttar Pradesh, India | |||
| Premier Fintrade Limited | ₹43.64 Lakh (FY 2024) | 53.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Starlit Pharma Ceuticals Pvt Ltd, buy the company report.
Auditor
Starlit Pharma Ceuticals Pvt Ltd is audited by BIJAN GHOSH & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BIJAN GHOSH & ASSOCIATES | FY 2023 | 323214E |
Shareholding
The shareholding of Starlit Pharma Ceuticals Pvt Ltd is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Starlit Pharma Ceuticals Pvt Ltd, buy the company report.
Legal cases
No court or tribunal cases involving Starlit Pharma Ceuticals Pvt Ltd are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Starlit Pharma Ceuticals Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Starlit Pharma Ceuticals has 2 associated companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
GST
No GST registration is on our record for Starlit Pharma Ceuticals Pvt Ltd; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Starlit Pharma Ceuticals Pvt Ltd has 2 board changes on record since 1994: 2 appointments. The latest: Rajesh Kumar Jain was appointed as Director on 29 May 2006.
Frequently asked questions
Starlit Pharma Ceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in investment and credit nbfc, within the financial services industry. It was incorporated on 21 January 1992 (34+ years old) and is registered under CIN U24234WB1992PTC054185.
Starlit Pharma Ceuticals has 2 current directors:
- Manoj Jain - Director
- Rajesh Kumar Jain - Director
The latest financial statements of Starlit Pharma Ceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 06 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Starlit Pharma Ceuticals is U24234WB1992PTC054185. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Starlit Pharma Ceuticals was incorporated on 21 January 1992, making it 34+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Starlit Pharma Ceuticals by revenue are Amrit Financial Services Pvt Ltd,, Menchu's Finance Private Limited, Eros Merchants Pvt Ltd, Bhanumati Distributors Pvt.Ltd, Premier Fintrade Limited, all in the BFSI industry (NBFC Investment and Credit Companies, Small Non Deposit NBFC), with the same principal business activity (other financial activities).
Rajesh Kumar Jain was appointed as Director on 29 May 2006. Manoj Jain was appointed as Director on 06 Aug 1994.
The registered office of Starlit Pharma Ceuticals is at 6B Bentinck Street1St Floor Aloka House, Kolkata, West Bengal, India – 700001.
Starlit Pharma Ceuticals operates in the financial services industry, in the investment and credit nbfc segment.
The compliance status of Starlit Pharma Ceuticals is compliant as of 08 August 2026. The company is actively filing with the Registrar of Companies.
Starlit Pharma Ceuticals can be reached at its registered office: 6B Bentinck Street1St Floor Aloka House, Kolkata, West Bengal, India – 700001.